Acadia Healthcare Company Inc
$ 32.69
0.58%
28 Jul - close price
- Market Cap 3,006,402,000 USD
- Current Price $ 32.69
- High / Low $ 33.37 / 31.81
- Stock P/E N/A
- Book Value 21.58
- EPS -12.20
- Next Earning Report 2026-07-28
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE -0.41 %
- 52 Week High 35.83
- 52 Week Low 11.43
About
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral health facilities to serve the behavioral health and recovery needs of the communities in the United States. United States and Puerto Rico. The company is headquartered in Franklin, Tennessee.
Analyst Target Price
$32.21
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-07-28 | 2026-04-29 | 2026-02-25 | 2025-11-05 | 2025-08-05 | 2025-05-12 | 2025-02-27 | 2024-10-30 | 2024-07-31 | 2024-05-01 | 2024-02-27 | 2023-11-02 |
| Reported EPS | None | 0.37 | 0.07 | 0.72 | 0.83 | 0.4 | 0.64 | 0.91 | 0.91 | 0.84 | 0.85 | 0.91 |
| Estimated EPS | 0.33 | 0.26 | 0.1 | 0.67 | 0.71 | 0.36 | 0.7146 | 0.9 | 0.88 | 0.8 | 0.79 | 0.89 |
| Surprise | 0 | 0.11 | -0.03 | 0.05 | 0.12 | 0.04 | -0.0746 | 0.01 | 0.03 | 0.04 | 0.06 | 0.02 |
| Surprise Percentage | None% | 42.3077% | -30% | 7.4627% | 16.9014% | 11.1111% | -10.4394% | 1.1111% | 3.4091% | 5% | 7.5949% | 2.2472% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-28 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.33 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ACHC
2026-07-29 03:41:33
Acadia Healthcare (NASDAQ: ACHC) reported better-than-expected Q2 2026 earnings, with an actual EPS of $0.38 against a consensus of $0.35, and actual revenue of $865.84 million surpassing the expected $844.19 million. The company's Q2 earnings announcement occurred after market close on July 28, 2026, with a conference call scheduled for July 29, 2026, at 9:00 AM ET. Despite the positive earnings beat, other news highlights include ongoing class-action lawsuit information for stockholders and updated full-year 2026 guidance.
2026-07-29 00:41:33
Acadia Healthcare reported a decrease in Q2 adjusted earnings and revenue compared to the prior year. Despite this, the company raised its 2026 guidance, yet its shares still experienced an after-hours drop. This indicates investor apprehension even with a more positive long-term outlook.
2026-07-29 00:41:32
Acadia Healthcare Company Inc. has released its earnings summary for the quarter that ended on June 30. The full report is available via Refinitiv and is also accessible on TradingView, providing in-depth financial results for the company.
2026-07-28 20:41:32
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) reported a significant 64% drop in Q2 2026 net income to $10.9 million, despite largely flat revenue of $865.8 million, primarily due to higher professional and general liability (PLGL) costs and reduced supplemental payment program benefits. However, the company raised its full-year 2026 financial guidance for revenue, Adjusted EBITDA, and Adjusted EPS, anticipating improved operating cash flow and reduced capital expenditures. Acadia also expanded its capacity by opening new joint venture facilities and CTC locations, adding 240 licensed beds during the quarter.
2026-07-28 20:41:32
Acadia Healthcare Company (ACHC) stock has seen a significant 127.4% surge year-to-date, yet valuation checks suggest it may still be undervalued. The company screens as inexpensive on most metrics, including a P/S ratio of 0.9x compared to an implied fair P/S of 1.3x and an industry average of 1.5x. However, the market remains divided, with some investors seeing a strong turnaround potential and others concerned about execution and regulatory risks.
2026-07-28 19:41:33
Acadia Healthcare Company, Inc. (ACHC) reported Q2 adjusted EPS of $0.38 per share, surpassing the FactSet estimate of $0.35. The company also announced its Q2 revenue of $865.8 million, exceeding the FactSet estimate of $844.2 million. While Q2 adjusted earnings and revenue fell, the company raised its 2026 guidance, expecting an adjusted EPS range of $1.45-$1.60 and revenue between $3.40B-$3.45B.
